In order to better understand the inherent value and impact of ARTTM, Almac Clinical Technologies recently contracted with a third-party research firm to conduct a web-based survey in the second quarter of 2018 for the purpose of quantifying the time and effort required to conduct drug accountability & reconciliation tasks.
Click here to discover the substantial savings ($1.3M) when employing an automated accountability and reconciliation process within a trial's IRT system.
Find out the significant reductions in time and money for the following (on an average trial):
- Time spent per drug kit when reconciling supplies
- Time spent on resolving discrepancies, as well as accountability and reconciliation activities at sites
- Close-out activities, including time spent on-site to conduct A/R processes
